Home � Products & Services � Best Practice Database � Medical Affairs � Medical Affairs Excellence

Document Excerpt: Quantifying Impact & Telling the Value Story in Medical Affairs: Creating a Compelling Narrative for Top Management

ID: MD-864

Features:

6 Info Graphics

11 Data Graphics

250+ Metrics

15 Narratives

Pages/Slides: 4

Published: 2023

Delivery Format: Online PDF Document

License Options:
$0 - 1 user
$0 - Up to 5 users
$0 - Up to 20 users

Download FREE Excerpt

919-403-0251

Schedule a Meeting

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study - click here

This excerpt includes research findings and metrics from document #5764 “Quantifying Impact & Telling the Value Story in Medical Affairs: Creating a Compelling Narrative for Top Management”.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Biopharmaceutical; Medical Device; Manufacturing; Consumer Products; Chemical; Clinical Research; Laboratories

Companies Profiled:
Abbott; Adaptimmune; ASC Therapeutics; Astellas; AstraZeneca; Baxter International; Bayer; bioMerieux; Boehringer Ingelheim; Domp�; Dermavant Sciences; Eisai; Eli Lilly; Genentech; GlaxoSmithKline ; GRAIL; Grifols; Jazz Pharmaceuticals; Merck; Myovant Sciences; Novartis; Novo Nordisk; OTSUKA; Pfizer; Roche; Sage Therapeutics; Sanofi; Santen; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd; Vertex Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.